ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, supplying promising breakthroughs across many healthcare and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, more trusted alternate for therapeutic use, notably i